Mojisola Adeyeye, director-general of the National Agency for Food and Drug Administration and Control (NAFDAC) has declared the agency’s readiness to eliminate substandard and falsified medicines in the country through a partnership with pre-shipment agents in China and India.
The move is part
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```